New webinar recording: NGS for clinically relevant mutations in circulating tumor DNA

WBNR_2ScreenConference_700x233

Are you still missing low-frequency alleles in your samples? Looking for ways to increase the sensitivity of your NGS assays and find clinically relevant mutations? Dr. Clifford Tepper from UC Davis presented a very interesting webinar on the application of new targeted NGS assays to identify new mutations in circulating tumor DNA (ctDNA). He discussed multiple approaches to increase the sensitivity of NGS assays and showed how NGS data analysis can be performed efficiently and quickly without being an expert in bioinformatics. Listen to the webinar and send us your questions.

Listen to the webinar! 

Krishnan Allampallam, Ph.D.

Senior Global Marketing Manager, Translational Sciences

Dr. Krishnan Allampallam has spent over 10 years in the biotechnology industry. Before beginning his career in biotech, Dr. Allampallam worked on pathophysiology of myelodysplastic syndrome and authored and co-authored multiple publications, abstracts and book chapters. He received his Ph.D. from University of Toledo Medical Center in 1996 and did post-doctoral research at The Cleveland Clinic and Rush University Medical Center. He has been at QIAGEN since 2008.

Your email address will not be published. Required fields are marked *